CB1 Cannabinoid Receptors Drive the Memory Problems That Occur During Nicotine Withdrawal
In mice, cognitive deficits during nicotine withdrawal were caused by increased 2-AG signaling through CB1 receptors on GABAergic neurons, and blocking CB1 receptors prevented both the memory impairment and associated brain structural changes.
Quick Facts
What This Study Found
Researchers discovered that the cognitive deficits occurring during nicotine withdrawal are mediated by the endocannabinoid system, specifically through CB1 receptors on inhibitory (GABAergic) neurons.
During nicotine withdrawal in mice, 2-AG levels (but not anandamide) increased. This 2-AG surge, acting through CB1 receptors on GABA neurons, caused memory impairment. Blocking CB1 receptors with rimonabant or genetically deleting CB1 receptors specifically from GABA neurons prevented the cognitive deficits.
The withdrawal also caused structural brain changes: mature dendritic spines on hippocampal CA1 neurons decreased at day 4 of withdrawal, and this decrease correlated with memory performance. These structural changes were normalized in mice lacking CB1 receptors on GABA neurons and by rimonabant treatment.
Key Numbers
2-AG levels increased during nicotine withdrawal (anandamide unchanged). 2-AG synthesis inhibitor O7460 abolished cognitive deficits. CB1 antagonist rimonabant prevented memory impairment. Mature dendritic spines decreased at day 4 of withdrawal. Spine density correlated with memory performance.
How They Did This
Nicotine withdrawal was precipitated by the nicotinic antagonist mecamylamine in mice. Multiple pharmacological (rimonabant, 2-AG synthesis inhibitor O7460, 2-AG degradation inhibitor JZL184) and genetic (conditional CB1 receptor knockout on GABA neurons) approaches were used. Memory was assessed behaviorally. Dendritic spine density was quantified on hippocampal neurons.
Why This Research Matters
Cognitive difficulties during nicotine withdrawal are a major predictor of relapse in people trying to quit smoking. Identifying the endocannabinoid system as the mechanism driving these cognitive deficits opens a potential therapeutic target. If CB1 modulation could prevent withdrawal-related cognitive impairment, it might help smokers quit more successfully.
The Bigger Picture
This study reveals a surprising connection between the endocannabinoid and nicotinic systems. The finding that endocannabinoid signaling drives cognitive problems during nicotine withdrawal has implications beyond smoking cessation. It suggests that cannabis use during nicotine withdrawal attempts could potentially worsen cognitive symptoms by further activating the same CB1 receptor pathway.
What This Study Doesn't Tell Us
Mouse model of precipitated withdrawal may not fully replicate the gradual withdrawal humans experience when quitting smoking. Rimonabant was withdrawn from the human market due to psychiatric side effects, limiting direct clinical translation. The study examined a specific type of memory; other cognitive domains were not assessed.
Questions This Raises
- ?Would cannabis use during nicotine withdrawal worsen the cognitive deficits by activating the same CB1 pathway?
- ?Could safer CB1 modulators be developed for smoking cessation support?
- ?Do the structural brain changes reverse completely with extended abstinence?
Trust & Context
- Key Stat:
- Blocking CB1 receptors prevented both cognitive deficits and structural brain changes during nicotine withdrawal
- Evidence Grade:
- Preliminary evidence from an animal study using multiple complementary approaches (pharmacological and genetic).
- Study Age:
- Published in 2017. Important preclinical finding linking endocannabinoid and nicotinic systems.
- Original Title:
- CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal.
- Published In:
- Biological psychiatry, 81(7), 625-634 (2017)
- Authors:
- Saravia, Rocio(2), Flores, África(2), Plaza-Zabala, Ainhoa, Busquets-Garcia, Arnau, Pastor, Antoni, de la Torre, Rafael, Di Marzo, Vincenzo, Marsicano, Giovanni, Ozaita, Andrés, Maldonado, Rafael, Berrendero, Fernando
- Database ID:
- RTHC-01510
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does using cannabis make it harder to quit smoking?
This study suggests it could. The memory problems during nicotine withdrawal are driven by increased endocannabinoid signaling through CB1 receptors. THC in cannabis also activates CB1 receptors, which could theoretically amplify the same pathway causing cognitive difficulties. However, this was an animal study and the question has not been definitively answered in humans.
Why do people have trouble thinking clearly when quitting nicotine?
This study identified a specific mechanism: during nicotine withdrawal, the brain produces more of the endocannabinoid 2-AG, which acts on CB1 receptors on inhibitory neurons. This disrupts normal hippocampal function and even causes physical changes (loss of dendritic spines) on memory-related neurons.
Read More on RethinkTHC
- 30-days-without-weed
- 420-sober-survival-guide
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBT-cannabis-recovery
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cannabis-relapse-cycle-pattern
- cant-enjoy-anything-without-weed
- cold-turkey-vs-taper-quit-weed
- creativity-without-weed-quitting-artist-musician
- dating-sober-after-quitting-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- hobbies-after-quitting-weed
- how-to-quit-weed
- identity-after-quitting-weed
- journaling-weed-withdrawal
- leaving-stoner-culture-identity
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- money-saved-quitting-weed-calculator
- nervous-system-weed-withdrawal-fight-flight
- one-year-sober-weed
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-creativity
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-face-changes-skin
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- quitting-weed-weight-loss-gain
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- teen-weed-use-under-18-effects-brain
- telling-friends-quitting-weed
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-reward-system-brain
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-01510APA
Saravia, Rocio; Flores, África; Plaza-Zabala, Ainhoa; Busquets-Garcia, Arnau; Pastor, Antoni; de la Torre, Rafael; Di Marzo, Vincenzo; Marsicano, Giovanni; Ozaita, Andrés; Maldonado, Rafael; Berrendero, Fernando. (2017). CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal.. Biological psychiatry, 81(7), 625-634. https://doi.org/10.1016/j.biopsych.2016.07.007
MLA
Saravia, Rocio, et al. "CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal.." Biological psychiatry, 2017. https://doi.org/10.1016/j.biopsych.2016.07.007
RethinkTHC
RethinkTHC Research Database. "CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Str..." RTHC-01510. Retrieved from https://rethinkthc.com/research/saravia-2017-cb1-cannabinoid-receptors-mediate
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.